What Is a Trichome and Why Does It Matter in Medical Cannabis?

The Biology of Trichomes: Cannabis’s Chemical Factories

• Trichomes are microscopic glandular structures found on the surface of cannabis flower and leaves
• Three types: bulbous (smallest), capitate-sessile (medium), and capitate-stalked (largest and most pharmacologically relevant)
• Capitate-stalked trichomes contain the head — a secretory disc cell cluster — where cannabinoids and terpenes are synthesised
• Trichome density and maturity are key determinants of a cannabis product’s potency and therapeutic quality

The trichome is the fundamental unit of cannabis pharmacology. Every cannabinoid and terpene that gives a medical cannabis product its therapeutic profile is synthesised within these tiny resin glands. Understanding trichome biology allows clinicians and patients to interpret product quality documentation more accurately and to understand why visual assessment of cannabis flower — trichome density, colour, and preservation — is a meaningful quality indicator.

Cannabinoid Biosynthesis Within the Trichome

• THC and CBD are not synthesised directly — their acidic precursors THCA and CBDA are produced in the trichome head
• Decarboxylation (heat) converts THCA to THC and CBDA to CBD, activating pharmacological activity
• Terpene synthesis occurs alongside cannabinoid production in the same secretory cells
• The ratio of THCA to CBDA in a given plant is determined by genetics (THCA synthase vs CBDA synthase expression)

The distinction between acidic (THCA, CBDA) and neutral (THC, CBD) forms is clinically important. Raw cannabis flower contains predominantly THCA, not THC. This is why patients cannot simply eat raw flower and expect psychoactive or therapeutic effects — decarboxylation must occur first, either through heating in a vaporiser or through the manufacturing process of cannabis oil preparations.

Trichome Maturity and Harvest Timing

• Clear/translucent trichomes: immature, lower cannabinoid content, less sedative terpene profile
• Milky/cloudy trichomes: peak THC/CBD production, optimal harvest point for most medical applications
• Amber trichomes: THC is partially degrading to CBN (cannabinol), producing a more sedative, less potent product
• Optimal harvest timing is determined by examining trichomes under 40–60× magnification

In EU-GMP certified cultivation, trichome maturity assessment is a standard quality control step. Products harvested at peak trichome maturity, under optimal post-harvest conditions, will have higher cannabinoid content and greater terpene preservation than those harvested late or processed suboptimally. The CoA cannabinoid values reflect the product at a specific point in its shelf life — storage conditions after harvest affect trichome integrity and cannabinoid stability.

Trichome Preservation: From Cultivation to Patient

• Temperature: excessive heat degrades terpenes and cannabinoids; cold chain management preserves trichome integrity
• Humidity: 55–62% RH is ideal for cannabis storage; too dry causes trichome brittleness; too moist causes mould
• Mechanical handling: rough handling crushes trichomes, releasing and degrading terpenes prematurely
• Packaging: nitrogen-flushed, airtight containers protect trichomes from oxidation and moisture during storage and transport

For prescribers and pharmacists, understanding trichome preservation reinforces the importance of supply chain quality. Cannabis products that arrive from importers in damaged packaging, that have been stored outside temperature and humidity specifications, or that show visual signs of mechanical damage represent a quality risk. EU-GMP certified supply chains are designed to maintain trichome integrity from harvest through to dispensing.